Medindia

X

Enzyme, a Target for New Drugs Against Tuberculosis Identified

by Rathi Manohar on  November 19, 2010 at 9:54 PM Research News   - G J E 4
A key enzyme in Mycobacterium tuberculosis helping the microbe to multiply rapidly has been discovered by scientists who view it as the target for new drugs to treat tuberculosis (TB).
 Enzyme, a Target for New  Drugs Against Tuberculosis Identified
Enzyme, a Target for New Drugs Against Tuberculosis Identified
Advertisement

The human equivalent of this enzyme has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies.

Advertisement
Scientists at the University of Birmingham have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.

The enzyme called IMPDH is crucial for the survival of both human and bacterial cells. It is involved in the first stage of producing guanine nucleotides -the raw materials needed for DNA synthesis - as well as many other housekeeping processes that keep the cell alive and functioning.

The researchers identified the three genes in M. tuberculosis that encode IMPDH and then screened a library of 16 compounds that were likely to impede its function to some extent.

Of the 16 diphenyl urea (DPU) compounds, 3 were able to inhibit IMPDH by more than 90%, killing M. tuberculosis cells.

The study was published in Microbiology on 17 November.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All